Invasive Meningococcal Disease, 2011-2020, and Impact of the COVID-19 Pandemic, England

Emerg Infect Dis. 2021 Sep;27(9):2495-2497. doi: 10.3201/eid2709.204866. Epub 2021 Jun 30.

Abstract

Invasive meningococcal disease incidence in England declined from 1.93/100,000 persons (1,016 cases) in 2010-11 to 0.95/100,000 (530 cases) in 2018-19 and 0.74/100,000 in 2019-20 (419 cases). During national lockdown for the coronavirus disease pandemic (April-August 2020), incidence was 75% lower than during April-August 2019.

Keywords: 2019 novel coronavirus disease; COVID-19; England; Neisseria meningitidis; SARS-CoV2; United Kingdom; bacteria; bacterial co-infections; case fatality rate; coronavirus; coronavirus disease; meningococcal disease; meningococcal vaccines; severe acute respiratory syndrome coronavirus 2; viruses; zoonoses.

MeSH terms

  • COVID-19*
  • Communicable Disease Control
  • England / epidemiology
  • Humans
  • Meningococcal Infections* / epidemiology
  • Meningococcal Vaccines*
  • Neisseria meningitidis*
  • Pandemics
  • SARS-CoV-2

Substances

  • Meningococcal Vaccines